Amplify Seymour Cannabis ETF (CNBS) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
P/E 21.87 means the share price is 21.87 times one year of earnings per share. Beta 0.18: the stock has moved about 82% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAmplify Seymour Cannabis ETF (CNBS) trades at $26.23. Amplify Seymour Cannabis ETF (CNBS) is an actively managed ETF providing diversified exposure to the U.S. cannabis ecosystem. Sector: Financials.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for CNBS: CNBS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Amplify Seymour Cannabis ETF (CNBS) Financial Services Profile
Amplify Seymour Cannabis ETF (CNBS) offers investors diversified exposure to the U.S. cannabis industry, encompassing plant cultivation, support services, and ancillary businesses. As an actively managed ETF, CNBS aims to achieve capital appreciation by strategically allocating investments across the cannabis value chain, distinguishing itself through its focused U.S. market approach.
What Is the Investment Thesis for CNBS?
Amplify Seymour Cannabis ETF (CNBS) presents a focused investment opportunity within the U.S. cannabis market. With a market capitalization of $0.08 billion and a beta of 0.18, CNBS offers exposure to a high-growth sector with relatively low volatility compared to the broader market. The primary value driver is the continued expansion and legalization of cannabis across U.S. states, creating new market opportunities for companies within the cannabis ecosystem. Upcoming catalysts include potential federal regulatory reforms and increasing consumer acceptance of cannabis products. However, potential risks include regulatory uncertainty, competition from established players, and market volatility. The ETF's active management strategy aims to capitalize on these growth opportunities while mitigating risks, making it a potentially noteworthy option for investors seeking exposure to the U.S. cannabis market.
Based on FMP financials and quantitative analysis
CNBS Key Highlights
Market Cap: $0.08B indicates the fund's size and potential for growth within the cannabis sector.
- Beta: 0.18 suggests lower volatility compared to the broader market, potentially offering a more stable investment in a high-growth sector.
- Actively Managed: The fund's active management allows for strategic adjustments based on market conditions and regulatory changes, potentially enhancing returns.
- U.S. Focus: CNBS provides targeted exposure to the U.S. cannabis market, capitalizing on the growth potential within the evolving U.S. regulatory landscape.
- Diversified Exposure: CNBS invests across the cannabis ecosystem, encompassing companies involved in cannabis cultivation, support services, and ancillary businesses, mitigating risk through diversification.
Who Are CNBS's Competitors?
CNBS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ACSI American Customer Satisfaction ETF | $74.72 | -0.43% | $111M | — |
| BMVP Invesco Bloomberg MVP Multi-factor ETF | $51.73 | -0.06% | $96.9M | — |
| FLJH Franklin FTSE Japan Hedged ETF | $46.33 | +0.37% | $185M | — |
| INCE Franklin Income Equity Focus ETF | $65.68 | +0.01% | $122M | — |
| JPXN iShares JPX-Nikkei 400 ETF | $102.89 | -0.52% | $138M | — |
| BX Blackstone Inc. | $112.25 | +0.14% | $136B | 67 5-pillar |
| APOS Apollo Global Management, Inc. | $25.65 | +0.04% | $75.0B | 55 5-pillar |
| BAM Brookfield Asset Management | $44.56 | -0.04% | $71.2B | 59 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CNBS's Key Strengths?
Diversified exposure to the U.S. cannabis market.
- Active management strategy.
- Focus on U.S.-based companies.
- Established track record.
What Are CNBS's Weaknesses?
Relatively small market capitalization.
- Concentrated exposure to the cannabis industry.
- Dependence on regulatory developments.
- Potential for high volatility.
What Are the Key Risks for CNBS?
Rich valuation — a P/E of 21.87 runs well above the Financial Services sector’s ~13.80x, leaving little room for a miss.
- Regulatory uncertainty and changes in cannabis laws.
- Competition from established players in the cannabis industry.
- Market volatility and fluctuations in cannabis stock prices.
- Changes in consumer preferences and demand for cannabis products.
- Dependence on regulatory developments for growth.
What Are CNBS's Competitive Advantages?
- Diversified exposure to the U.S. cannabis market.
- Active management strategy to optimize returns.
- Focus on U.S.-based companies.
- Established track record in the cannabis ETF space.
What Does CNBS Do?
Amplify Seymour Cannabis ETF (CNBS) is an actively managed exchange-traded fund (ETF) designed to provide investors with diversified exposure to the burgeoning U.S. cannabis industry. Launched with the objective of capital appreciation, CNBS strategically invests across the cannabis ecosystem, encompassing companies involved in cannabis cultivation, support services, and ancillary businesses. The ETF's investment strategy focuses exclusively on U.S.-based companies, capitalizing on the growth potential within the evolving U.S. cannabis market. CNBS actively manages its portfolio, adapting to market dynamics and regulatory changes to optimize investment outcomes. By offering a diversified portfolio of cannabis-related companies, CNBS seeks to mitigate risk while capturing the upside potential of this rapidly expanding sector. The fund's active management approach allows for strategic adjustments based on market conditions and regulatory developments, aiming to enhance returns for investors seeking exposure to the U.S. cannabis industry. CNBS provides a vehicle for investors to participate in the growth of the U.S. cannabis market through a diversified and actively managed ETF structure.
What Products and Services Does CNBS Offer?
- Invests in U.S. companies involved in cannabis cultivation.
- Provides exposure to companies supporting the cannabis industry.
- Includes companies providing ancillary services to the cannabis sector.
- Actively manages its portfolio to optimize investment outcomes.
- Seeks capital appreciation through strategic investments.
- Offers a diversified portfolio of cannabis-related companies.
- Adapts to market dynamics and regulatory changes.
How Does CNBS Make Money?
- Generates revenue through management fees charged to investors.
- Invests in a diversified portfolio of cannabis-related companies.
- Actively manages its portfolio to maximize returns.
- Distributes capital gains to investors.
What Industry Does CNBS Operate In?
The asset management industry is undergoing significant transformation, driven by technological advancements, changing investor preferences, and increasing regulatory scrutiny. ETFs like CNBS are gaining popularity as investors seek diversified exposure to specific sectors and themes. The cannabis industry, while still nascent, is experiencing rapid growth due to increasing legalization and acceptance. CNBS is positioned to capitalize on this growth by providing investors with a convenient and diversified way to access the U.S. cannabis market. The competitive landscape includes other ETFs and investment vehicles focused on the cannabis sector, each with its own investment strategy and risk profile.
Who Are CNBS's Key Customers?
- Retail investors seeking exposure to the cannabis industry.
- Institutional investors looking for diversified cannabis investments.
- Financial advisors seeking to add cannabis exposure to client portfolios.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 38 snapshots
| 2026-08-23 | 44 |
| 2026-08-30 | 44 |
| 2026-09-06 | 44 |
| 2026-09-13 | 44 |
| 2026-09-20 | 44 |
| 2026-09-29 | 44 |
| 2026-10-01 | 44 |
What changed?
The score has stayed at 44.
Over the same 30 days the stock moved -8.3%.
CNBS Financials
Bull Case vs Bear Case
Bull Case
- Diversified exposure to the U.S. cannabis market.
- Active management strategy.
- Focus on U.S.-based companies.
- Established track record.
Bear Case
- Relatively small market capitalization.
- Concentrated exposure to the cannabis industry.
- Dependence on regulatory developments.
- Potential for high volatility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CNBS Latest News
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · Dec 18, 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · Dec 17, 2025
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · Aug 5, 2025
-
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
benzinga · Jun 10, 2025
CNBS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CNBS.
Price Targets
Wall Street price target analysis for CNBS.
CNBS MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CNBS; grades run from A+ (80-100) to F (below 30).
Latest News
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
ETFs that hold CNBS
Funds in our ETF coverage that list CNBS among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| Amplify Alternative Harvest ETF (MJ) | 47.15% |
CNBS Financials Stock FAQ
What do analysts say about CNBS stock?
Generally, analysts covering ETFs in the cannabis sector focus on factors such as regulatory developments, market growth rates, and the ETF's investment strategy. Key valuation metrics include the ETF's net asset value (NAV), expense ratio, and tracking error.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- The cannabis industry is subject to evolving regulations and market conditions.